| Date | Title | Description | Source |
| 10.02.2023 | Rezolute Reports Second Quarter Fiscal 2023 Results and High... | /EIN News/ -- Initiated Phase 2 proof-of-concept study of RZ402
Anticipate initiation of global Pha... | einpresswi... |
| 20.10.2022 | Rezolute Announces Presentation at The Retina Society 55th A... | REDWOOD CITY, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-st... | globenewsw... |
| 15.09.2022 | Rezolute Reports Fourth Quarter and Full Year Fiscal 2022 Re... | Announced a $130 million registered direct offering and concurrent private placement priced at-the-m... | globenewsw... |
| 07.09.2022 | Rezolute Announces Presentation at the 60th Annual ESPE Meet... | Data from Phase 2b RIZE Study in congenital hyperinsulinism will be presented in oral presentation
... | globenewsw... |
| 07.09.2022 | NANOBIOTIX与联拓生物宣布，用于评估NBTXR3治疗头颈癌的NANORAY-312 III期试验在亚洲完成首位患... | 针对Nanobiotix治疗头颈癌的关键性III期试验,其区域启动工作按计划推进，联拓生物在亚洲完成首位患者招募此项合作继续增强联拓生物在亚洲的行业领导地位，同时，Nanobiotix将继续专注于计划... | globenewsw... |
| 12.05.2022 | Rezolute Reports Third Quarter Fiscal 2022 Financial Results... | Announced a $130 million registered direct offering and concurrent private placement
Positive topli... | globenewsw... |
| 04.05.2022 | Rezolute to Host Corporate Update Call on May 4, 2022 | REDWOOD CITY, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-sta... | globenewsw... |
| 04.05.2022 | Rezolute, Inc. Announces Closing of Registered Direct Offeri... | REDWOOD CITY, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-sta... | globenewsw... |
| 01.05.2022 | Rezolute Announces Positive Data from its Phase 2b (RIZE) St... | Highly significant ~75% reduction in hypoglycemia events at anticipated therapeutic doses
≥50% impr... | globenewsw... |
| 01.05.2022 | Rezolute, Inc. Announces Aggregate $130 Million Registered D... | REDWOOD CITY, Calif., May 01, 2022 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-sta... | globenewsw... |
| 26.04.2022 | RZ358 Phase 2b (RIZE Study) Topline Data to be Unveiled at P... | Rezolute to host conference call presentation and discussion of the data on Sunday, May 1 at 2:30 p.... | globenewsw... |
| 29.03.2022 | Rezolute Joins the Rare Disease Company Coalition | REDWOOD CITY, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-s... | globenewsw... |
| 23.03.2022 | Rezolute Announces Positive Results from the Phase 2b RIZE S... | The RIZE study demonstrated highly significant improvements in hypoglycemia and good safety and tole... | globenewsw... |
| 08.03.2022 | TRexBio Completes $26 Million Series A Extension Led by Pola... | SOUTH SAN FRANCISCO, Calif., March 8, 2022 — TRexBio Inc., a discovery stage company decoding human ... | svhealthin... |
| 09.02.2022 | Rezolute Reports Second Quarter Fiscal 2022 Financial Result... | REDWOOD CITY, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-st... | globenewsw... |
| 06.01.2022 | SV Created TRexBio Announces Collaboration with Janssen to D... | South San Francisco, Calif., Jan. 6, 2022 – TRex Bio Inc., a discovery stage company decoding tissue... | svhealthin... |
| 02.11.2021 | Candel Therapeutics to Participate in Three Upcoming Investo... | NEEDHAM, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Nasdaq: CADL), a late c... | globenewsw... |
| 20.09.2021 | Intrance Medical Systems Raises $8 Million to Support Develo... | Intrance Medical Systems Raises $8 Million to Support Development of its Innovative Therapy for Adva... | news.cisio... |
| 29.07.2021 | Cepheid : Receives CE-IVD Clearance for Two Next-Generation ... | SUNNYVALE, Calif., July 29, 2021 /PRNewswire/ -- Today Cepheid announced that it has received CE-IVD... | marketscre... |
| 22.06.2021 | TRexBio Closes the Final Tranche of $59 Million Series A Fin... | June 22, 2021 08:00 AM Eastern Daylight Time
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--TRexBio,... | svhealthin... |
| 17.05.2021 | Imbria Pharmaceuticals Presents Phase 1 and Preclinical Data... | May 17, 2021 08:00 AM Eastern Daylight Time
BOSTON--(BUSINESS WIRE)--Imbria Pharmaceuticals, a clin... | svhealthin... |
| 24.03.2021 | New Data Show Foreign Reference Drug Pricing Proposals Would... | SAN FRANCISCO, SAN DIEGO, LOS ANGELES & WASHINGTON--(BUSINESS WIRE)--Mar 24, 2021--
Biocom Cali... | oaoa.com/n... |
| 22.03.2021 | Spruce Biosciences Reports Fourth Quarter and Full Year 2020... | SAN FRANCISCO--(BUSINESS WIRE)--Mar 22, 2021--
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stag... | oaoa.com/n... |
| 22.03.2021 | PhaseBio Announces Closing of Public Offering of Common Stoc... | MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--Mar 22, 2021--
PhaseBio Pharmaceuticals, Inc. (Nasda... | oaoa.com/n... |
| 17.03.2021 | Spruce Biosciences Presents Phase 1 and 2 Data for Tildacerf... | SAN FRANCISCO--(BUSINESS WIRE)--Mar 17, 2021--
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stag... | oaoa.com/n... |
| 15.03.2021 | Silverback Therapeutics Announces the Appointment of Dr. Mar... | SEATTLE--(BUSINESS WIRE)--Mar 15, 2021--
Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”... | oaoa.com/n... |
| 15.03.2021 | PhaseBio Reports Fourth-Quarter and Full-Year 2020 Financial... | MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--Mar 15, 2021--
PhaseBio Pharmaceuticals, Inc. (Nasda... | oaoa.com/n... |
| 11.03.2021 | Taysha Gene Therapies Announces Participation in Upcoming Ma... | DALLAS--(BUSINESS WIRE)--Mar 11, 2021--
Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centr... | oaoa.com/n... |
| 11.03.2021 | PhaseBio Pharmaceuticals and BioVectra Enter into Supply Agr... | MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--Mar 11, 2021--
PhaseBio Pharmaceuticals, Inc. (Nasda... | oaoa.com/n... |
| 11.03.2021 | Study Published in the European Journal of Oral Sciences Fea... | SAN DIEGO & COPENHAGEN, Denmark--(BUSINESS WIRE)--Mar 11, 2021--
AFYX Therapeutics (“AFYX”), a ... | oaoa.com/n... |
| 09.03.2021 | Taysha Gene Therapies Announces Collaboration to Advance Nex... | DALLAS--(BUSINESS WIRE)--Mar 9, 2021--
Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centri... | oaoa.com/n... |
| 01.03.2021 | Taysha Gene Therapies to Release Full-Year 2020 Financial Re... | DALLAS--(BUSINESS WIRE)--Mar 1, 2021--
Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (“Taysha”), a pat... | oaoa.com/n... |
| 26.02.2021 | Taysha Gene Therapies Announces Support of Rare Disease Day ... | DALLAS--(BUSINESS WIRE)--Feb 26, 2021--
Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centr... | oaoa.com/n... |
| 26.02.2021 | PhaseBio Pharmaceuticals to Participate in Upcoming Investor... | MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--Feb 26, 2021--
PhaseBio Pharmaceuticals, Inc. (Nasda... | oaoa.com/n... |
| 23.06.2020 | SV Health Investors notes Gilead Sciences Secures Exclusive ... | SV Health Investors (“SV”) is delighted by the announcement by Gilead Sciences, Inc of its acquisiti... | svhealthin... |
| 25.05.2019 | EPIC SCIENCES APPOINTS LLOYD SANDERS AS CHIEF EXECUTIVE OFFI... | SAN DIEGO, Calif., March 25, 2019 – Epic Sciences, Inc. (Epic) today announced that Lloyd Sanders ha... | blueoxhcp.... |
| 22.05.2019 | EPIC SCIENCES APPOINTS NEW CHIEF TECHNOLOGY OFFICER | San Diego – May 22, 2019 – Epic Sciences, Inc. announced today that it has named Chockalingam “Palan... | blueoxhcp.... |
| 22.04.2019 | EPIC SCIENCES APPOINTS RICHARD J. WENSTRUP, M.D. AS CHIEF ME... | San Diego, CA, April 22, 2019. — Epic Sciences, Inc. announced today the appointment of Richard J. W... | blueoxhcp.... |
| 08.08.2016 | Helsinn Group and MEI Pharma Enter Strategic Agreement for t... | MEI Pharma to receive $20 million in near-term cash payments, plus up to $444 million in potential m... | 3bfuturehe... |
| 28.10.2015 | Hot processor speeds up UK genome analysis | Hot processor speeds up UK genome analysis
28-10-2015
The Genome Analysis Centre (TGAC) is the fir... | cambridgen... |
| - | Xencor Reports Fourth Quarter and Full Year 2020 Financial R... | MONROVIA, Calif.--(BUSINESS WIRE)--Feb 23, 2021--
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biop... | oaoa.com/n... |
| - | ShangPharma Innovation Names Two Executives-In-Residence | SOUTH SAN FRANCISCO, Calif., Oct. 24, 2017 – ShangPharma Innovation Inc., a global venture capital f... | spiivc.com... |
| - | ShangPharma Innovation Appoints Mohamad Moghadam-Tabrizi as ... | ShangPharma Innovation (SPI) today announced the appointment of Mohamad Moghadam-Tabrizi to the posi... | spiivc.com... |
| - | ShangPharma Innovation portfolio company Tilos Therapeutics ... | KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canad... | spiivc.com... |
| - | Endpoints: When VCs hand out mega-rounds to Vir and Gossamer... | “Following a period of unprecedented returns for biopharma investors, flush VCs are sinking bigger a... | spiivc.com... |
| - | ShangPharma Innovation and SRI International Announce Drug D... | Strategic partnership to target Alzheimer’s disease and other neurodegenerative and inflammatory con... | spiivc.com... |
| - | BioWorld: Other news to note | “Shangpharma Innovation Inc., of South San Francisco, inked a multiyear strategic collaboration with... | spiivc.com... |
| - | Xencor to Present at the Barclays Global Healthcare Conferen... | MONROVIA, Calif.--(BUSINESS WIRE)--Mar 3, 2021--
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage bioph... | oaoa.com/n... |
| - | New York Business Journal: ShangPharma Innovation partners w... | “Venture capital firm ShangPharma Innovation Inc. is teaming up with the Icahn School of Medicine at... | spiivc.com... |
| - | PhaseBio Announces Pricing of Public Offering of Common Stoc... | MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--Mar 17, 2021--
PhaseBio Pharmaceuticals, Inc. (Nasda... | oaoa.com/n... |
| - | Xencor to Present Preclinical Data from Four Preclinical XmA... | MONROVIA, Calif.--(BUSINESS WIRE)--Mar 10, 2021--
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage bio... | oaoa.com/n... |
| - | ShangPharma Innovation and the University of California San ... | — New innovation group and leading medical center partner on novel approach to advance therapies acr... | spiivc.com... |
| - | ShangPharma Innovation and Icahn School of Medicine at Mount... | SOUTH SAN FRANCISCO, California and NEW YORK, Jan. 16, 2017 — ShangPharma Innovation Inc., a global ... | spiivc.com... |
| - | Partners HealthCare raises $171 million to invest in early-s... | Boston, Massachusetts., Nov. 8, 2017 – Exclusively dedicated to the development of breakthrough tech... | spiivc.com... |
| - | ShangPharma Innovation Names New Executives-In-Residence | SOUTH SAN FRANCISCO, California, June 7, 2017 — ShangPharma Innovation, Inc. (SPII) announced the ad... | spiivc.com... |
| - | BioSpace: ShangPharma Innovation and Icahn School of Medicin... | “ShangPharma Innovation Inc., a global venture capital firm focused on biomedical R&D therapeuti... | spiivc.com... |
| - | ShangPharma Innovation Expands Incubator to Drive Life Scien... | SOUTH SAN FRANCISCO, California, March 19, 2018 — ShangPharma Innovation Inc., a global venture capi... | spiivc.com... |
| - | Outsourcing-Pharma: SRI teams up with ShangPharma to target ... | “ShangPharma Innovation and SRI International are collaborating to develop treatments for neurodegen... | spiivc.com... |
| - | PhaseBio Pharmaceuticals to Host Virtual Investor and Analys... | MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--Feb 24, 2021--
PhaseBio Pharmaceuticals, Inc. (Nasda... | oaoa.com/n... |
| - | MedCity News: Is too much money being invested in oncology? | “Between venture capitalists flush with cash and corporate mergers and acquisitions, money is gushin... | spiivc.com... |
| - | PhaseBio Announces Proposed Public Offering of Common Stock | MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--Mar 17, 2021--
PhaseBio Pharmaceuticals, Inc. (Nasda... | oaoa.com/n... |
| - | BioCentury: ShangPharma, Icahn In R&D Deal | “ShangPharma Innovation Inc. (South San Francisco, Calif.) will fund preclinical research at the Ica... | spiivc.com... |
| - | Endpoints: AveXis wants $400M more for promising SMA gene th... | “ShangPharma Innovation, a VC firm that focuses on seed investments, has struck a deal with Icahn Sc... | spiivc.com... |
| - | Taysha Gene Therapies Reports Full-Year 2020 Financial Resul... | DALLAS--(BUSINESS WIRE)--Mar 3, 2021--
Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centri... | oaoa.com/n... |
| - | FierceBiotech: ShangPharma boosts Bay Area reach for early-s... | “Venture capital firm ShangPharma Innovation is growing its life science incubator on the West Coast... | spiivc.com... |
| - | ShangPharma Innovation Names Founding Executive-In-Residence... | SOUTH SAN FRANCISCO, California, June 2, 2017 — ShangPharma Innovation (SPI) announced the appointme... | spiivc.com... |
| - | Spruce Biosciences to Announce Phase 1 and 2 Data of Tildace... | SAN FRANCISCO--(BUSINESS WIRE)--Mar 2, 2021--
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage... | oaoa.com/n... |
| - | The Scripps Research Institute and ShangPharma Innovation An... | La Jolla, California (June 8, 2017) – The Scripps Research Institute (TSRI) and ShangPharma Innovati... | spiivc.com... |
| - | ShangPharma Innovation Appoints Walter H. Moos as CEO | SAN FRANCISCO, April 10, 2017 —ShangPharma Innovation, a newly incorporated division of the ShangPha... | spiivc.com... |
